efegatran has been researched along with cgp 39393 in 1 studies
Studies (efegatran) | Trials (efegatran) | Recent Studies (post-2010) (efegatran) | Studies (cgp 39393) | Trials (cgp 39393) | Recent Studies (post-2010) (cgp 39393) |
---|---|---|---|---|---|
43 | 3 | 0 | 136 | 25 | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bacher, P; Bajusz, S; Breddin, K; Fareed, J; Iqbal, O; Walenga, JM | 1 |
1 other study(ies) available for efegatran and cgp 39393
Article | Year |
---|---|
The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal models.
Topics: Amino Acid Sequence; Animals; Anticoagulants; Blood Coagulation; Dose-Response Relationship, Drug; Fibrinolytic Agents; Hirudin Therapy; Hirudins; Jugular Veins; Molecular Sequence Data; Oligopeptides; Rabbits; Recombinant Proteins; Thrombosis | 1993 |